Europe - Frankfurt Stock Exchange - FRA:NXU - DE0005220909 - Common Stock
The current stock price of NXU.DE is 71.2 EUR. In the past month the price increased by 0.28%. In the past year, price increased by 4.09%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| EQS.PA | EQUASENS | 18.12 | 656.86M | ||
| GPI.MI | GPI SPA | 20.99 | 455.04M | ||
| ALCGM.PA | CEGEDIM SA | N/A | 195.28M | ||
| ALMDT.PA | MEDIAN TECHNOLOGIES | N/A | 161.38M | ||
| AGFB.BR | AGFA-GEVAERT NV | N/A | 75.55M | ||
| AJ91.DE | DOCCHECK AG | 12.12 | 63.88M | ||
| M3V.DE | MEVIS MEDICAL SOLUTIONS AG | 9.84 | 44.77M | ||
| ALINS.PA | INTRASENSE SAS | N/A | 12.07M | ||
| MLLAB.PA | MEDIA LAB SPA | N/A | 8.48M |
NEXUS AG engages in the development and sale of software and hardware solutions. The company is headquartered in Donaueschingen, Baden-Wuerttemberg and currently employs 1,971 full-time employees. The company went IPO on 2000-07-24. The firm is engaged in the development, trade and service of software solutions for facilities of the healthcare system. The company is divided into three divisions: NEXUS/ DE (Germany), NEXUS/ DIS (Diagnostic systems) and NEXUS/ ROE (Rest of Europe). The firm has different product groups such as: NEXUS/ HISng, an information system for somatic hospitals in Germany; NEXUS/ PSYCHIATRY, an information system for psychiatric institutions; NEXUS/ REHAng, an information system for rehabilitation facilities; NEXUS/ ITR, a software for rehabilitation, private, acute care clinics not providing surgery and hotels with medical care; NEXUS/ ARCHIVE and NEXUS/ PEGASOS, provides archiving and process management in healthcare, among others.
NEXUS AG
Irmastrasse 1
Donaueschingen BADEN-WUERTTEMBERG DE
Employees: 1909
Phone: 49771229600
NEXUS AG engages in the development and sale of software and hardware solutions. The company is headquartered in Donaueschingen, Baden-Wuerttemberg and currently employs 1,971 full-time employees. The company went IPO on 2000-07-24. The firm is engaged in the development, trade and service of software solutions for facilities of the healthcare system. The company is divided into three divisions: NEXUS/ DE (Germany), NEXUS/ DIS (Diagnostic systems) and NEXUS/ ROE (Rest of Europe). The firm has different product groups such as: NEXUS/ HISng, an information system for somatic hospitals in Germany; NEXUS/ PSYCHIATRY, an information system for psychiatric institutions; NEXUS/ REHAng, an information system for rehabilitation facilities; NEXUS/ ITR, a software for rehabilitation, private, acute care clinics not providing surgery and hotels with medical care; NEXUS/ ARCHIVE and NEXUS/ PEGASOS, provides archiving and process management in healthcare, among others.
The current stock price of NXU.DE is 71.2 EUR. The price decreased by -0.14% in the last trading session.
NEXUS AG (NXU.DE) has a dividend yield of 0.32%. The yearly dividend amount is currently 0.22.
NXU.DE has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
NEXUS AG (NXU.DE) has a market capitalization of 1.23B EUR. This makes NXU.DE a Small Cap stock.
You can find the ownership structure of NEXUS AG (NXU.DE) on the Ownership tab.
ChartMill assigns a technical rating of 4 / 10 to NXU.DE. When comparing the yearly performance of all stocks, NXU.DE turns out to be only a medium performer in the overall market: it outperformed 44.11% of all stocks.
ChartMill assigns a fundamental rating of 7 / 10 to NXU.DE. NXU.DE has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company.
Over the last trailing twelve months NXU.DE reported a non-GAAP Earnings per Share(EPS) of 1.97. The EPS increased by 26.97% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 12.11% | ||
| ROA | 6.93% | ||
| ROE | 11.27% | ||
| Debt/Equity | 0.05 |
7 analysts have analysed NXU.DE and the average price target is 71.4 EUR. This implies a price increase of 0.28% is expected in the next year compared to the current price of 71.2.
For the next year, analysts expect an EPS growth of 14.6% and a revenue growth 9.04% for NXU.DE